ethoxyidazoxan has been researched along with apraclonidine in 1 studies
Studies (ethoxyidazoxan) | Trials (ethoxyidazoxan) | Recent Studies (post-2010) (ethoxyidazoxan) | Studies (apraclonidine) | Trials (apraclonidine) | Recent Studies (post-2010) (apraclonidine) |
---|---|---|---|---|---|
14 | 2 | 0 | 427 | 98 | 56 |
Protein | Taxonomy | ethoxyidazoxan (IC50) | apraclonidine (IC50) |
---|---|---|---|
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.004 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.004 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.004 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Convents, A; De Backer, JP; De Keyser, J; De Vos, H; Vauquelin, G | 1 |
1 other study(ies) available for ethoxyidazoxan and apraclonidine
Article | Year |
---|---|
Identification of alpha 2 adrenoceptors in the human nucleus olivarius by radioligand binding.
Topics: Adrenergic alpha-Agonists; Aged; Binding, Competitive; Brain Chemistry; Clonidine; Dioxanes; Epinephrine; Humans; Idazoxan; Middle Aged; Olivary Nucleus; Radioligand Assay; Receptors, Adrenergic, alpha | 1992 |